spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 20 Jun 2008
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2008
Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER niacin/laropiprant) and MK-0524B (ER niacin/laropiprant/simvastatin)
Biopharmaceuticals
 HSMN NewsFeed - 20 Jun 2008
PDI Announces Retirement of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2008
ArQule Announces Appointment of Brian Schwartz as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2008
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Jun 2008
FDA Approves GlaxoSmithKline's AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 19 Jun 2008
Alpharma Announces Changes to Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2008
Biogen Idec Stockholders Elect Company's Board Nominees
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2008
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 19 Jun 2008
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Jun 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 18 Jun 2008
Santaris Pharma Appoints S0ren Tulstrup as New President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2008
GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 18 Jun 2008
Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2008
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2008
Vertex Pharmaceuticals Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2008
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 18 Jun 2008
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2008
Pfizer and Ranbaxy Settle Lipitor Patent Litigation Worldwide
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 18 Jun 2008
CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jun 2008
FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 17 Jun 2008
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2008
Spectrum Pharmaceuticals Announces FUSILEV(TM) as Tradename for Levoleucovorin for Injection
Biopharmaceuticals
 HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jun 2008
Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS(TM) (triamcinolone acetonide injectable suspension) 80 mg/mL
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 Jun 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Jun 2008
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Jun 2008
Tercica Announces Results from Increlex(R) IGFD Patient Registry and Other Increlex(R) Studies at the 90th Meeting of the Endocrine Society
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
Lentigen Appoints Jim Meade as Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2008
Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2008
IRX Therapeutics Names Scott M. Freeman, M.D. Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2008
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jun 2008
EyeGate Pharma Appoints Amy Cohen as Vice President, Clinical Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 16 Jun 2008
FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Jun 2008
GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
OncoMed Pharmaceuticals Extends License Agreement for Use of MorphoSys's Core Technology
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 13 Jun 2008
U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Jun 2008
Study of VIDAZA(R) in Higher-Risk Patients with Myelodysplastic Syndromes Reports Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jun 2008
VIDAZA(R) Continues to Show Significant Overall Survival Benefit When Compared with Conventional Care Regimens Across the EU
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jun 2008
Positron Corporation Announces Sales & Marketing Agreement with NuView Radiopharmaceuticals
Biopharmaceuticals Radiology
 HSMN NewsFeed - 13 Jun 2008
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2008
Jamie Freedman, M.D., Ph.D. Appointed Chief Executive Officer of Locus Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2008
Pfizer Inc. and the University of Pennsylvania Announce $15 Million Partnership
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2008
Teva Announces Tentative Approval of Generic Diovan(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2008
ORENCIA(R) (abatacept) Provided an Increasing Degree of Inhibition of Structural Damage Through Three Years in Adults with Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 12 Jun 2008
Indevus Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2008
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2008
EpiCept Releases New Ceplene AML Data Demonstrating Leukemia Free Survival as Predictor of Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2008
Itero Biopharmaceuticals Inks Partnership With Indian Biotechnology Firm, Biological E.; Raises $21 Million Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2008
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2008
Neuro-Hitech, Inc. Announces Acquisition of MCR American Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2008
Phase 3 Data Show Efficacy of Golimumab in Patients with Active Rheumatoid Arthritis Previously Treated with Anti-TNF Agents
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2008
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2008
Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2008
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
Biopharmaceuticals Generics
 HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Mylan Wins Generic Prilosec(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Jun 2008
Merrimack Pharmaceuticals Raises $60 Million in Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Jun 2008
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Senior Pharmaceutical Executive, Glenn J. Gormley, M.D., Ph.D., to Lead Gemin X Pharmaceuticals as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Jun 2008
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jun 2008
New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)
Biopharmaceuticals
 HSMN NewsFeed - 10 Jun 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra(R) and Cimzia(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2008
Senetek PLC Announces Key Personnel Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2008
BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2008
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
Biopharmaceuticals Ophthalmology Drug Delivery Personnel
 HSMN NewsFeed - 9 Jun 2008
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Jun 2008
Orexo Strengthens the Executive Management Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2008
CytRx Corporation Signs Definitive Agreement to Acquire Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2008
Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Jun 2008
GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2008
US FDA grants pediatric exclusivity for UCB's Keppra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2008
Dyadic's Executive Officers and Key Employees Announce Their Resignation
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2008
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2008
MonoSol Rx Names Vincent Viviani Senior Vice President, Manufacturing and Operations
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 5 Jun 2008
FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jun 2008
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Ipsen to Acquire Tercica
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2008
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Bausch & Lomb Names Flemming Ornskov, M.D., MPH, as Global President, Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2008
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2008
Affymax(R) Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2008
Protez Pharmaceuticals to Be Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Jun 2008
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2008
Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2008
Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2008
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2008
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 3 Jun 2008
Provectus Pharmaceuticals Appoints Kelly M. McMasters, MD, PhD, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2008
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Jun 2008
Study of VIDAZA(R) in Higher-Risk Myelodysplastic Syndrome Patients Demonstrates Improved Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2008
Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2008
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p < 0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2008
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 2 Jun 2008
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
Banner Pharmacaps Receives FDA Approval for Amantadine Softgel Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jun 2008
Rexahn Pharmaceuticals Initiates Phase II Trial for Zoraxel(TM) to Treat Erectile Dysfunction
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2008
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
ABRAXANE(R) in Combination with Trastuzumab and Carboplatin Evaluated as First-Line Treatment for Patients with HER2-Positive Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Combination Therapy of Solvent-Free ABRAXANE(R) and the Targeted Therapy Bevacizumab Evaluated as First-Line Treatment for Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Jun 2008
Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jun 2008
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 2 Jun 2008
MethylGene Reports Clinical Data for MGCD0103 at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Celgene Withdraws European Union (EU) Marketing Authorization Application for Lenalidomide in Deletion-5Q Myelodysplastic Syndromes
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Jun 2008
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
Biopharmaceuticals Generics
 HSMN NewsFeed - 2 Jun 2008
Acorda Therapeutics Announces Positive Data from Second Phase 3 Study of Fampridine-SR on Walking Ability in People with Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jun 2008
Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jun 2008
Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
Updated REVLIMID(R) Data Presented in Newly Diagnosed Multiple Myeloma Presented at the 2008 American Society of Clinical Oncology (ASCO) Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2008
Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix(R) (panitumumab) in Combination with Standard Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 May 2008
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Premenopausal Women With Early-Stage Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Patients With Pancreatic Cancer can Benefit From Avastin(R) Plus Tarceva(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Data Confirm Avastin(R) Helps Patients With Metastatic Colorectal Cancer Live Even Longer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Amgen Reports Positive Data at ASCO from Three Studies of Denosumab in Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Interim Phase 2 Results of Open-Label Clinical Trial of Denosumab in Giant Cell Tumor of Bone Demonstrated 87 Percent Response Rate
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 May 2008
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2008
NCCN Previews Chemotherapy Order Templates(TM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
Lupin Receives USFDA Approval for Topiramate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2008
New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2008
Stem Cell Therapeutics Corp. Expands Executive Team by Appointing Thomas Franck as Vice President of Commercial Planning
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 30 May 2008
Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Biopharmaceuticals Orthopaedic Surgery
 HSMN NewsFeed - 30 May 2008
Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 May 2008
Biogen Idec Names Hans Peter Hasler Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2008
Bristol-Myers Squibb to Acquire Kosan Biosciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2008
Charles J. Bramlage Named President of Covidien Pharmaceutical Products Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Biopharmaceuticals
 HSMN NewsFeed - 29 May 2008
InSite Vision Signs AzaSite(R) Licensing and Distribution Agreement with Essex Bio-Technology for People's Republic of China
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 29 May 2008
Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 May 2008
Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
MonoSol Rx Appoints John McCracken Senior Vice President Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 28 May 2008
Pfizer Names Amy W. Schulman as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 May 2008
XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2008
Nventa Appoints Gordon H. Busenbark to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2008
ARIAD Appoints Former Bristol-Myers Squibb Executive to Lead Corporate Legal and Compliance Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2008
Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 May 2008
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
Sonus Pharmaceuticals and OncoGenex Technologies to Merge
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 May 2008
ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
Santarus Announces Development Program for New ZEGERID Prescription Product
Biopharmaceuticals
 HSMN NewsFeed - 28 May 2008
New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 27 May 2008
Cyclacel's Sapacitabine Receives Orphan Designation for AML & MDS From EU Regulators
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 May 2008
Nanomedicine Company Nanobiotix Elects Former Sanofi-Aventis Oncology Researcher Elsa Borghi, MD, as its Medical Director
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 27 May 2008
King Pharmaceuticals Exercises Option to License Third Opioid Product Utilizing Acura's AVERSION Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 May 2008
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 May 2008
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2008
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 May 2008
EpiCept Files Re-Examination Documentation for Marketing Authorization of Ceplene(TM) in Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 May 2008
Osmotica Pharmaceutical Receives FDA Approval to Market Novel Forms of Extended Release Venlafaxine HCl
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2008
Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 May 2008
Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 May 2008
DOR BioPharma Opens New Corporate Office in United Kingdom
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2008
New Evidence Advocates the use of Enbrel to Combat and Effectively Control the Debilitating Symptoms of Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 May 2008
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2008
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 22 May 2008
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 May 2008
DOR BioPharma Provides Update on orBec(R) European Regulatory and Development Strategy
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 22 May 2008
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 22 May 2008
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 May 2008
Ipsen: Appointment of Gerard Picot as Vice President, Global Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2008
New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2008
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 21 May 2008
Lilly Announces Changes in Key Leadership Roles
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2008
QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 21 May 2008
Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 May 2008
Merck Resolves Investigations Under State Consumer Protection Statutes Related to VIOXX
Biopharmaceuticals Litigation
 HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 20 May 2008
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2008
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2008
NovaDel Announces European License Agreement for Ondansetron Oral Spray
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 May 2008
Penwest Enters Into Development and Licensing Agreement With Cobalt Laboratories
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 May 2008
Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 May 2008
GlycoVaxyn Appoints Philippe Dro as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert M. Brenner, M.D. as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Phase 3 GATTEX(TM) Results Presented at Annual Digestive Disease Week Congress Highlight Potential New Treatment in Short Bowel Syndrome
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 May 2008
Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Premier Hospitals, Healthcare Providers to Save with New Pricing on Two Pfizer Branded Antifungal Products
Biopharmaceuticals Group Purchasing
 HSMN NewsFeed - 19 May 2008
CytoDyn Appoints Dr. Nader Z. Pourhassan Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Miragen Therapeutics, Inc. Receives $8 M in Venture Capital Financing for Development of MicroRNA-based Therapies
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2008
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 May 2008
Bayer Announces Availability of Reformulated Liquid Leukine(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2008
InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 May 2008
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 19 May 2008
Kythera Biopharmaceuticals Announces $40M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 May 2008
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2008
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2008
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 16 May 2008
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2008
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2008
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 May 2008
CDC Recommends ZOSTAVAX(R), Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
Cambrex Appoints Steven M. Klosk as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Surface Logix Announces Executive Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Forbes Medi-Tech Announces Corporate Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2008
Valeant Pharmaceuticals Announces FDA Has Initiated Reconsideration of Generic Efudex(R) Approval
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 15 May 2008
Sepracor Names Robert F. Scumaci as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
David P. Southwell to Resign as Chief Financial Officer of Sepracor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Haemacure appoints Reinaldo M. Diaz to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 May 2008
Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 May 2008
Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 May 2008
Pfizer Names Garry Nicholson to Head New Oncology Business Unit
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2008
Takeda Completes Acquisition of Millennium
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2008
Carticept Medical Reports First Patients Treated in Pivotal Study of Agilus(TM) Therapy for Pain Associated with Ankle Osteoarthritis
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 14 May 2008
New Data Shows 45 Percent of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) and BENICAR HCT(R)
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 May 2008
TyRx Pharma, Inc. Announces the First Human Implant of the AIGISRX(TM) Anti-Bacterial Envelope in Cardiac Patient
Devices Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 May 2008
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 14 May 2008
New Data Support Routine Childhood Vaccination With PREVENAR in Europe
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Sosei Announces Outcome of Strategy Review
Biopharmaceuticals
 HSMN NewsFeed - 13 May 2008
Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 13 May 2008
Skinvisible Signs Licensing Agreement for Two Acne Formulations
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 13 May 2008
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
Biopharmaceuticals
 HSMN NewsFeed - 13 May 2008
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 May 2008
Medimetriks Pharmaceuticals, Inc. Begins Operations
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 13 May 2008
Vyteris Announces Appointments of President and Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 May 2008
Cipher provides regulatory update for CIP-TRAMADOL ER
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2008
Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2008
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
Biopharmaceuticals
 HSMN NewsFeed - 12 May 2008
Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2008
Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2008
Mystic Pharmaceuticals(TM) Expands Management, Engineering and Scientific Team with Key Hires
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 May 2008
LUNESTA(R) Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 12 May 2008
Novalar Receives FDA Approval for OraVerse(TM)
Biopharmaceuticals FDA Dental
 HSMN NewsFeed - 12 May 2008
Revance Announces Series C Expansion
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 May 2008
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2008
AmerisourceBergen Announces Streamlined Organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2008
Adolor Provides Regulatory Update on Entereg(R) (alvimopan)
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2008
Spectrum Pharmaceuticals Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.
Biopharmaceuticals Generics
 HSMN NewsFeed - 9 May 2008
ZIOPHARM Receives FDA Orphan Drug Designation for Palifosfamide (ZIO-201) in the Treatment of Soft Tissue Sarcoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 May 2008
EUSA Pharma Completes Acquisition Of Cytogen Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2008
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 May 2008
U.S. Navy Receives Funding for Further Development of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2008
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2008
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2008
New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 8 May 2008
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 May 2008
Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 May 2008
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 May 2008
Orexigen(R) Therapeutics Announces Completion of Patient Enrollment in Phase III Clinical Program for Contrave(R)
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Par Pharmaceutical Acquires Spectrum Pharmaceutical's Interest In Sumatriptan Injection
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2008
Spectrum Pharmaceuticals Receives $20 Million Cash Payment from Par Pharmaceutical for Sumatriptan Injection
Biopharmaceuticals
 HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 May 2008
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2008
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
Auspex Pharmaceuticals Announces Series B Financing; Appointment of Ajit Gill as President and Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 6 May 2008
Apoptos Inc. Raises $28 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 May 2008
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
REGiMMUNE Raises $8,000,000 in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 May 2008
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 May 2008
GTx Appoints Kenneth S. Robinson, MD to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
Tranzyme Pharma Strengthens Clinical Development Team With the Appointment of Philippa A. Charlton, MD, MPH as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2008
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
Biopharmaceuticals Radiology Licensing
 HSMN NewsFeed - 5 May 2008
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2008
Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2008
Ipsen: Adenuric(R) (Febuxostat) Receives Marketing Authorisation in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 May 2008
European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 May 2008
Nordic Capital Fund VII and Avista Capital Partners Agree to Acquire ConvaTec Business for approximately $4.1 Billion
Biopharmaceuticals Devices Wound Care
 HSMN NewsFeed - 2 May 2008
Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 May 2008
GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2008
Valeant Pharmaceuticals Reduces Headcount
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2008
Esperion Therapeutics Completes $22.75 M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 May 2008
Abbott, Takeda Conclude TAP Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2008
XenoPort Appoints Vincent J. Angotti as Chief Commercialization Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2008
Dr. Reddy's Announces the Completion of Two Acquisitions
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 May 2008
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2008
Anesiva Announces Expansion of Zingo Agreement in Europe
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor Announces Final Settlement of XOPENEX(R) Inhalation Solution Patent Infringement Litigation with Breath Limited
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement for XOPENEX(R)/Ipratropium Inhalation Solution Combination
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Apr 2008
APP Pharmaceuticals Names Thomas H. Silberg Chief Executive Officer; Appoints Richard J. Tajak Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2008
ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (Recombinant) Spray Study in Burn Patients
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 30 Apr 2008
GSK Announces Changes to Corporate Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Biopharmaceuticals Devices Drug Delivery Oncology FDA
 HSMN NewsFeed - 30 Apr 2008
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 Apr 2008
CoNCERT Pharmaceuticals Raises $37 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Apr 2008
Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 30 Apr 2008
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Apr 2008
Neuromed Names Sean Cunliffe Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2008
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Devices Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 29 Apr 2008
Noven Appoints Peter C. Brandt as President, Chief Executive Officer & Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2008
Constellation Pharmaceuticals Closes $32 Million in Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Apr 2008
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Apr 2008
Mylan Announces Final FDA Approval for Trandolapril Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Apr 2008
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Apr 2008
Merck Receives Not Approvable Letter from FDA for MK-0524A (ER niacin/laropiprant)
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2008
Teva Announces Approval of Generic Flolan(R) for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Apr 2008
Nuon Therapeutics Inc. Completes $27 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Apr 2008
Alfacell Announces Retirement of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Apr 2008
Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
Biopharmaceuticals Surgery Licensing
 HSMN NewsFeed - 28 Apr 2008
Hyperion Therapeutics Names Bruce F. Scharschmidt CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2008
North Park Aesthetics Acquires Exclusive Worldwide Rights to Develop and Commercialize Fluridil, a Novel Antiandrogen for Androgenetic Alopecia
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2008
Labopharm Appoints Dr. Claire Brullé as Senior Vice-President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2008
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!